EchoGo® Heart Failure vs Cleerly ISCHEMIA
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is designed for detecting Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing echocardiograms, providing rapid insights for clinical decisions. In contrast, Tool B focuses on non-invasively determining the likelihood of coronary artery ischemia at a vessel level through CCTA scan analysis, aiding in personalized diagnosis and treatment planning for coronary artery disease. Therefore, while both are cardiology AI tools, they serve distinct diagnostic purposes by utilizing different imaging modalities and targeting different cardiac conditions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. Cleerly ISCHEMIA, on the other hand, analyzes CCTA scans to determine the likelihood of coronary artery ischemia at a vessel level.
EchoGou00ae Heart Failure utilizes routine echocardiogram video clips as its input for analysis. Cleerly ISCHEMIA requires Coronary Computed Tomography Angiography (CCTA) scans to perform its assessment of coronary arteries.
EchoGou00ae Heart Failure delivers automated structured reports via a DICOM workflow to PACS, integrating seamlessly with existing IT stacks. Cleerly ISCHEMIA provides comprehensive interactive web-based reports and integrates with PowerScribe via API, with data transfer facilitated by Cleerly Proxy (VPN or virtual appliance).
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For Cleerly ISCHEMIA, pricing varies by provider, and physicians are advised to contact Cleerly for details, though Cleerly Proxy is provided without additional charge.
EchoGou00ae Heart Failure provides AI-powered HFpEF detection with clinically validated performance (90% sensitivity, 86% specificity). Cleerly ISCHEMIA offers non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization, and stenosis severity assessment.
EchoGou00ae Heart Failure is relevant for Cardiology, Emergency Medicine, and Internal Medicine. Cleerly ISCHEMIA is primarily designed for Cardiology and Radiology specialties.
EchoGou00ae Heart Failure delivers insights within 20 minutes of analysis. The time to receive results for Cleerly ISCHEMIA is not specified in the provided information.
More Comparisons
Backers
Who funded each tool's parent company.